Possible Involvement of bcl-2 Suppression in Wild-Type p53 Gene-Dependent Cell Growth Repression in Rat Osteosarcoma Cells

Toxicologic Pathology

Volumn 28, Issue 4, 2000, Pages 575-579

  Honoki, Kanya ^a   Tsujiuchi, Toshifumi ^a   Tsutsumi, Masahiro ^a   Kido, Akira ^a   Morishita, Toru ^a   Yoshimoto, Masatoshi ^a   Miyauchi, Yoshizumi ^a   Mii, Yoshio ^a   Tamai, Susumu ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

apoptosis; bax; bcl 2; Osteosarcoma; p53; rat; waf1 p21

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; GENE THERAPY; LUNG METASTASIS; NONHUMAN; OSTEOSARCOMA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL DIVISION; DNA FRAGMENTATION; DNA, NEOPLASM; GENES, BCL-2; GENES, P53; HUMANS; OSTEOSARCOMA; PLASMIDS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; RODENTIA;

EID: 0033853928     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800411     Document Type: Article

References (32)

1. Berges RR, Furuya Y., Remington L., English HF, Jacks T., Isaacs JT (1993). Cell proliferation, DNA repair, and p53 function are not required for programmed cell death of prostatic glandular cells induced by androgen ablation. Proc Natl Acad Sci USA 90: 8910-8914.
2. Chiou SK, Rao L., White E. (1994). Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 14: 2556-2563.
3. Clarke AR, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Myllie AH (1993). Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362: 849-852.
4. Dahlin DC, Coventry MB (1967). Osteogenic sarcoma: A study of six hundred cases. J Bone Joint Surg 49: 101-110.
5. Diller L., Kassel J., Nelson CE, Gryka MA, Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker SJ, Vogelstein B., Friend SH (1990). p53 function as a cell cycle protein in osteosarcoma. Mol Cell Biol 10: 5772-5781.
6. Finley CA, Hinds PW, Levine AJ (1989). The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093.
7. Fujiwara T., Cai DW, Georges RN, Mukhopadhyay T., Grimm EA, Roth JA (1994). Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. J Natl Cancer Inst 86: 1458-1462.
8. Ginsberg D., Michael MD, Ginsberg D., Oren M. (1991). Induction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of protein. Mol Cell Biol 11: 582-585.
9. Hollstein M., Sidransky D., Vogelstein B., Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53.
10. Honoki K., Mori T., Tsutsumi M., Tsujiuchi T., Kido A., Morishita T., Miyauchi Y., Dohi Y., Mii Y., Tamai S., Konishi Y. (1998). Heterogeneous pattern of gene expression in cloned cell lines established from a rat transplantable osteosarcoma lung metastatic nodule. Cancer Lett 127: 221-228.
11. Honoki K., Tsutsumi M., Miyauchi, Y., Mii Y., Tsujiuchi T., Morishita T., Miura S., Aoki M., Kobayashi E., Tamai S., Konishi Y. (1993). Increased expression of nucleoside diphosphate kinase/nm23 and c-Ha-ras mRNA is associated with spontaneous lung metastasis in rat-transplantable osteosarcomas. Cancer Res 53: 5038-5042.
12. Kastan MB, Zhan Q., el-Deiry WS, Carrier F., Jacks T., Walsh WV, Plunkett BS, Vogelstein B., Fornace AJ (1992). A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-teleangiectasia. Cell 71: 587-597.
13. Kido A., Tsujiuchi T., Tsutsumi M., Takahama M., Okajima E., Kobitsu K., Miyauchi Y., Mii Y., Tamai S., Konishi Y. (1997). p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats. Cancer Lett 112: 5-10.
14. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.
15. Lowe SW, Schmitt EM, Smith SW, Osborne BA, Jacks T. (1993). p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849.
16. Marcellus RC, Teodoro JG. Charbonneau R., Shore G., Branton PE (1996) Expression of p53 in Saos-2 osteosarcoma cells induces apoptosis which can be inhibited by Bcl-2 or the adenovirus E1B 55 kDa protein. Cell Growth Differ 7: 1643-1650.
17. Mii Y., Tsutsumi M., Shiraiwa K., Miyauchi Y., Honoki K., Maruyama H., Ohgushi H., Masuhara K., Konishi Y. (1988). Transplantable osteosarcomas with high lung metastatic potential in Fischer 344 rats. Jpn J Cancer Res 79: 589-592.
18. Miyashita T., Harigai M., Hanada M., Reed JC (1994). Identification of a p53-dependent negative response element in the bcl-2 gene. Cancer Res 54: 3131-3135.
19. Miyashita T., Krajewski S., Krajewska M., Wang HG, Lin HK, Liebermann DA, Hoffman B., Reed JC (1994). Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799-1805.
20. Miyasita T., Reed JC (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80: 293-299.
21. Nigro JM, Baker SJ, Preisinger AC, et al (13 coauthors) (1989). Mutations in the p53 gene occur in diverse human tumour types. Nature 342: 705-708.
22. Oltvai ZN, Milliman CL, Korsmeyer SJ (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74: 609-619.
23. Radinsky R., Fidler IJ, Price JE, Esumi N., Tsan R., Petty CM, Bucana CD, Bar-Eli M. (1994). Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 9: 1877-1883.
24. Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. (1992). The adenovirus E1A proteins induce apoptosis which is inhibited by the E1B 19K and Bcl-2 proteins. Proc Natl Acad Sci USA 89: 7742-7746.
25. Roth JA, Nguyen D., Lawrence DD, et al (21 coauthors) (1996). Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nature Med 2: 985-991.
26. Selins KS, Cohen JJ (1987). Gene induction by γ-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 139: 3199-3206.
27. Shimamura A., Fisher DE (1996). p53 in life and death. Clin Cancer Res 2: 435-440.
28. Sidransky D., Mikkelsen T., Schwechheimer K., Rosenblum ML, Cavanee W., Vogelstein B. (1992). Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355: 846-847.
29. Unni KK (1996). Dahlin's Bone Tumors, 5th ed. Lippincott and Raven, Philadelphia, pp 143-160.
30. Vogelstein B., Kinzler KW (1992). p53 function and dysfunction. Cell 70: 523-526.
31. Wang J., Bucana CD, Roth JA, Zhang WW (1995). Apoptosis induced in human ostesarcoma cells is one of the mechanisms for cytocidal effect of Ad5CMV-p53. Cancer Gene Ther 2: 9-17.
32. Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. (1991). Wild type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin-6. Nature 352: 345-347.